Cargando…
Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation
The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664585/ https://www.ncbi.nlm.nih.gov/pubmed/33223781 http://dx.doi.org/10.1007/s12144-020-01193-2 |
_version_ | 1783609863437287424 |
---|---|
author | Bernardo, Allan B. I. Mendoza, Norman B. Simon, Patricia D. Cunanan, Angela Lorraine P. Dizon, John Ian Wilzon T. Tarroja, Maria Caridad H. Ma. Balajadia-Alcala, Araceli Saplala, Jesus Enrique G. |
author_facet | Bernardo, Allan B. I. Mendoza, Norman B. Simon, Patricia D. Cunanan, Angela Lorraine P. Dizon, John Ian Wilzon T. Tarroja, Maria Caridad H. Ma. Balajadia-Alcala, Araceli Saplala, Jesus Enrique G. |
author_sort | Bernardo, Allan B. I. |
collection | PubMed |
description | The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who might need mental health services. In developing the scale items, we considered previous research and theory on anxiety symptoms and symptoms reported by clinically referred cases in the Philippines. The scale was validated in a Filipino sample (N = 925). Exploratory factor analysis indicated two factors corresponding to somatic and non-somatic symptoms; confirmatory factor analysis showed good fit for the two-factor model. CPAS-11 showed good internal consistency, convergent and divergent validity, and screening accuracy. A cutoff score of 15 showed adequate sensitivity and specificity to distinguish GAD-7 screened participants. The results support the viability of CPAS-11 as a screening tool to identify individuals experiencing COVID-19-related anxiety. |
format | Online Article Text |
id | pubmed-7664585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-76645852020-11-16 Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation Bernardo, Allan B. I. Mendoza, Norman B. Simon, Patricia D. Cunanan, Angela Lorraine P. Dizon, John Ian Wilzon T. Tarroja, Maria Caridad H. Ma. Balajadia-Alcala, Araceli Saplala, Jesus Enrique G. Curr Psychol Article The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who might need mental health services. In developing the scale items, we considered previous research and theory on anxiety symptoms and symptoms reported by clinically referred cases in the Philippines. The scale was validated in a Filipino sample (N = 925). Exploratory factor analysis indicated two factors corresponding to somatic and non-somatic symptoms; confirmatory factor analysis showed good fit for the two-factor model. CPAS-11 showed good internal consistency, convergent and divergent validity, and screening accuracy. A cutoff score of 15 showed adequate sensitivity and specificity to distinguish GAD-7 screened participants. The results support the viability of CPAS-11 as a screening tool to identify individuals experiencing COVID-19-related anxiety. Springer US 2020-11-13 2022 /pmc/articles/PMC7664585/ /pubmed/33223781 http://dx.doi.org/10.1007/s12144-020-01193-2 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Bernardo, Allan B. I. Mendoza, Norman B. Simon, Patricia D. Cunanan, Angela Lorraine P. Dizon, John Ian Wilzon T. Tarroja, Maria Caridad H. Ma. Balajadia-Alcala, Araceli Saplala, Jesus Enrique G. Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation |
title | Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation |
title_full | Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation |
title_fullStr | Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation |
title_full_unstemmed | Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation |
title_short | Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation |
title_sort | coronavirus pandemic anxiety scale (cpas-11): development and initial validation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664585/ https://www.ncbi.nlm.nih.gov/pubmed/33223781 http://dx.doi.org/10.1007/s12144-020-01193-2 |
work_keys_str_mv | AT bernardoallanbi coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation AT mendozanormanb coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation AT simonpatriciad coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation AT cunananangelalorrainep coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation AT dizonjohnianwilzont coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation AT tarrojamariacaridadh coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation AT mabalajadiaalcalaaraceli coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation AT saplalajesusenriqueg coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation |